Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytoma, Malignant Fibrous × Blood Specimen Collection × 1 year × Clear all

Sponsor

Conditions

Neoplasms 37 Breast Neoplasms 37 Lung Neoplasms 21 Colorectal Neoplasms 18 Carcinoma, Non-Small-Cell Lung 17 Prostatic Neoplasms 13 Uterine Cervical Neoplasms 10 Head and Neck Neoplasms 10 Pancreatic Neoplasms 9 Carcinoma, Hepatocellular 9 Sarcoma 8 Ovarian Neoplasms 8 Myelodysplastic Syndromes 8 Melanoma 8 Multiple Myeloma 7 Glioma 7 Colonic Neoplasms 7 Brain Neoplasms 7 Hematologic Neoplasms 6 Esophageal Neoplasms 6 Endometrial Neoplasms 6 Disease 6 Neoplastic Cells, Circulating 5 Leukemia, Myeloid, Acute 5 Leukemia 5 Gastrointestinal Neoplasms 5 Uveal Melanoma 4 Skin Neoplasms 4 Neoplasm, Residual 4 Lymphoma, Non-Hodgkin 4

Interventions

pembrolizumab 4 Specimen Handling 3 Doxorubicin 3 Radiotherapy 2 Radiation 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 Biopsy 2 tremelimumab 1 talimogene laherparepvec 1 regorafenib 1 pazopanib 1 olaratumab 1 futibatinib 1 fludarabine 1 eribulin 1 durvalumab 1 cabozantinib 1 avelumab 1 aldesleukin 1 X-Rays 1 Trabectedin 1 Standard of Care 1 Quality of Life 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Histamine H2 Antagonists 1 Famotidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡